Scar sarcoidosis following rituximab therapy

被引：9
|
作者：
Vesely, Nicole C. [1 ]
Thomas, Renee M. [2 ]
Longo, Maria Isabel [2 ]
机构：
[1] Univ Florida, Coll Med, Dept Dermatol, Gainesville, FL USA
[2] Univ Florida Hlth, Dept Dermatol, 4037 NW 86th Terrace, Gainesville, FL 32606 USA
来源：
DERMATOLOGIC THERAPY | 2020年 / 33卷 / 06期
关键词：
rituximab; sarcoidosis; scar; CUTANEOUS SARCOIDOSIS;
D O I：
10.1111/dth.13693
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Drug-induced sarcoidosis has been rarely described but it constitutes a potential side effect of immunomodulatory medications. We report a case of rituximab-induced scar sarcoidosis and review similar published cases. Although there is evidence of B-cell dysregulation in the pathogenesis of sarcoidosis, the use of rituximab for this disease needs to be carefully evaluated based on reports of worsening and de novo development of sarcoidosis after rituximab therapy.
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Rituximab in refractory sarcoidosis: A single centre experience
    Cinetto F.
    Compagno N.
    Scarpa R.
    Malipiero G.
    Agostini C.
    Clinical and Molecular Allergy, 13 (1)
  • [22] Sarcoidosis mimicking metastatic thyroid cancer following radioactive iodine therapy
    Myint, Zin W.
    Chow, Robert D.
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2015, 5 (01):
  • [23] Extensive herpes zoster involvement following mycophenolate mofetil therapy for sarcoidosis
    Sandhya Hegde
    Radha Annamalai
    Jyotirmay Biswas
    Journal of Ophthalmic Inflammation and Infection, 2012, 2 (1) : 47 - 48
  • [24] Prognostic Factors Predicting Remission Following Rituximab Therapy for Pemphigus Vulgaris
    Raviv, Tal
    Pevzner, Keren
    Barzilai, Aviv
    Pavlotsky, Felix
    Baum, Sharon
    ACTA DERMATO-VENEREOLOGICA, 2025, 105
  • [25] Systemic adverse events following rituximab therapy in patients with Graves’ disease
    D. El Fassi
    C. H. Nielsen
    P. Junker
    H. C. Hasselbalch
    L. Hegedüs
    Journal of Endocrinological Investigation, 2011, 34 : e163 - e167
  • [26] Systemic adverse events following rituximab therapy in patients with Graves' disease
    El Fassi, D.
    Nielsen, C. H.
    Junker, P.
    Hasselbalch, H. C.
    Hegedus, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (07) : E163 - E167
  • [27] A Case of Sarcoidosis Which Developed on the Smallpox Vaccine Scar
    Karaca, Nezih
    Ertam, Ilgen
    Kilinc-Karaarslan, Isil
    Kazandi, Ali Can
    Dereli, Tugrul
    TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY, 2007, 1 (01): : 27 - 28
  • [28] Scar Sarcoidosis Developing 16 Years after Complete Excision of an Eyelid Basal Carcinoma
    Tawfik, Hatem A.
    Assem, Maher
    Elkafrawy, Mamdouh H.
    Talib, NorLaila M.
    ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY, 2008, 27 (06): : 438 - 440
  • [29] SARS-CoV-2 Humoral Immunity Persists Following Rituximab Therapy
    Lu, Liangjian
    Chan, Chang Yien
    Lim, Yi Yang
    Than, Mya
    Teo, Sharon
    Lau, Perry Y. W.
    Ng, Kar Hui
    Yap, Hui Kim
    Plans-Rubio, Pedro
    VACCINES, 2023, 11 (12)
  • [30] Autoimmune Sequelae Following Rituximab Therapy A Review of the Literature and Potential Immunologic Mechanisms
    Kersh, Anna E.
    Feldman, Ron J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 (08) : 427 - 435
12345